International Journal of Otolaryngology / 2014 / Article / Tab 1

Clinical Study

The Effect of Topical Application of Royal Jelly on Chemoradiotherapy-Induced Mucositis in Head and Neck Cancer: A Preliminary Study

Table 1

Patients’ profile.

CaseGroupTumor siteSexAge (year)TNM stageICCRT

1RJLarynxM59T2N0M0S-1
2RJOropharynxM84T3N2cM0S-1
3RJHypopharynxM62TXN3M0S1 + NN + T
4RJHypopharynxM58T1N3M0S1 + NN + T
5RJLarynxF75T2N0M0S-1
6RJOropharynxM65T4aN2bM0CDDP
7RJHypopharynxM51T2N2bM0N + T
8CONTHypopharynxM84T2N0M0S-1
9CONTOropharynxM63T1N2bM0N + T
10CONTOropharynxM62T1N2aM0CDDP
11CONTOropharynxM65T4aN0M0S1 + NN + T
12CONTHypopharynxM66T2N1M0S1 + NS-1
13CONTMaxillary sinusM78T4aN0M0CDDP

RJ: royal jelly, CONT: control, M: male, and F: female.
IC: induction chemotherapy.
CRT: chemoradiotherapy.
S1 + N: S1 + nedaplatin.
S1: S-1 regimen.
N + T: Weekly nedaplatin and docetaxel regimen.
CDDP: Cisplatin regimen.